Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline
YP Chen, N Ismaila, MLK Chua, AD Colevas… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to
practicing physicians and other healthcare providers on definitive-intent chemoradiotherapy …
practicing physicians and other healthcare providers on definitive-intent chemoradiotherapy …
Nasopharyngeal carcinoma: clinical achievements and considerations among treatment options
Z Liu, Y Chen, Y Su, X Hu, X Peng - Frontiers in oncology, 2021 - frontiersin.org
Nasopharyngeal carcinoma (NPC) is a severe malignancy arising from the nasopharyngeal
epithelium and is southern China's third most common cancer. With the advancement of …
epithelium and is southern China's third most common cancer. With the advancement of …
Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?
JJ Juarez-Vignon Whaley, M Afkhami… - … Treatment Options in …, 2023 - Springer
Opinion statement Nasopharyngeal carcinoma (NPC) is a rare malignancy, endemic in
China, that is commonly diagnosed in locally advanced scenarios. Its pathogenesis is …
China, that is commonly diagnosed in locally advanced scenarios. Its pathogenesis is …
Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: A prospective, non-randomised, phase 1 …
W Zhu, H Mei, L Jia, H Zhao, X Li, X Meng… - Investigational new …, 2020 - Springer
Radiation-induced oral mucositis has a dismal outcome with limited treatment options. We
conducted a phase I study to evaluate the safety and preliminary efficacy of epigallocatechin …
conducted a phase I study to evaluate the safety and preliminary efficacy of epigallocatechin …
The trajectory of oral mucositis in head and neck cancer patients undergoing radiotherapy and its influencing factors
M Liu, R An, Z Wu, L Dai, Q Zeng… - Ear, Nose & Throat …, 2024 - journals.sagepub.com
Background: Oral mucositis (OM) is a common and severe side effect of radiotherapy in
head and neck cancer (HNC). The study aimed to investigate the longitudinal changes in …
head and neck cancer (HNC). The study aimed to investigate the longitudinal changes in …
Patterns of oral mucositis in advanced oral squamous cell carcinoma patients managed with prophylactic photobiomodulation therapy—insights for future protocol …
M de Pauli Paglioni, KM Faria, NR Palmier… - Lasers in Medical …, 2021 - Springer
To characterize oral sites affected by radiation-induced oral mucositis (OM) and related
clinical outcomes in oral cancer patients subjected to prophylactic photobiomodulation …
clinical outcomes in oral cancer patients subjected to prophylactic photobiomodulation …
[HTML][HTML] Prediction of radiation-induced mucositis of H&N cancer patients based on a large patient cohort
Purpose/objective Radiation-induced mucositis is a severe acute side effect, which can
jeopardize treatment compliance and cause weight loss during treatment. The study aimed …
jeopardize treatment compliance and cause weight loss during treatment. The study aimed …
[HTML][HTML] Which induction chemotherapy regimen followed by cisplatin-based concurrent chemoradiotherapy is the best choice among PF, TP and TPF for …
Y He, T Guo, J Wang, Y Sun, H Guan… - Annals of Translational …, 2019 - ncbi.nlm.nih.gov
Background Which induction chemotherapy (IC) regimen followed by cisplatin-based
concurrent chemoradiotherapy (CCRT) is the best choice among PF (cisplatin and 5 …
concurrent chemoradiotherapy (CCRT) is the best choice among PF (cisplatin and 5 …
MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma
C Jiang, Z Cheng, T Jiang, Y Xu, B Wang - Genes & genomics, 2020 - Springer
Abstract Background MicroRNA-34a (miR-34a) has been reported to inhibit TGF-β
(transforming growth factor-β)-induced epithelial-mesenchymal transition (EMT) in …
(transforming growth factor-β)-induced epithelial-mesenchymal transition (EMT) in …
[HTML][HTML] Comparison of therapeutic efficacy and toxicity of docetaxel, cisplatin, and fluorouracil (TPF)-based induction chemotherapy plus concurrent …
R Chen, Y Lu, Y Zhang, R He, F Tang, W Yuan, Y Li… - Medicine, 2021 - journals.lww.com
Purpose: In recent years, docetaxel, cisplatin, and fluorouracil (TPF)-based induction
chemotherapy plus concurrent chemoradiotherapy (CCRT) has been commonly applied for …
chemotherapy plus concurrent chemoradiotherapy (CCRT) has been commonly applied for …